Molecular imaging using (nano)probes: cutting-edge developments and clinical challenges in diagnostics.

Area of Science:

• Biomedical engineering
• Medical imaging
• Nanotechnology

Background:

• Molecular imaging visualizes molecular and cellular processes, integrating with modalities like PET, MRI, CT, PAI, and FI.
• Advances in nanoprobe design, including multifunctional and targeted nanomaterials, have been made.

Purpose of the Study:

• Critically analyze challenges hindering clinical translation of molecular imaging nanoprobes.
• Identify specific barriers and propose strategies to overcome them, focusing on stability, biocompatibility, off-target effects, and sensitivity.

Main Methods:

• Review of existing literature on molecular imaging techniques and nanoprobe development.
• Analysis of obstacles such as nanoprobe stability, reticuloendothelial system accumulation, toxicity, and biodistribution.
• Exploration of strategies like surface modification, novel targeting ligands, and smart responsive systems.

Main Results:

• Nanoprobe clinical translation is limited by stability, nonspecific accumulation, toxicity, and manufacturing complexities.
• Key obstacles include poor stability in physiological environments and challenges in achieving optimal biocompatibility and controlled biodistribution.
• Complexity in synthesis and batch variability impede scalable manufacturing and regulatory approval.

Conclusions:

• Overcoming challenges in nanoprobe stability, biocompatibility, and sensitivity is crucial for clinical application.
• Developing multifunctional nanoprobes for simultaneous diagnosis and therapy will advance personalized medicine.
• This review provides a roadmap for optimizing nanoprobes to bridge the gap between research and clinical reality.